IDEXX Laboratories, Inc. (IDXX)
- Previous close
555.80 - Open
559.14 - Bid 559.19 x 100
- Ask 501.77 x 100
- Day's range
553.57 - 561.83 - 52-week range
500.61 - 769.98 - Volume
43,543 - Avg. Volume
547,906 - Market cap (intra-day)
43.667B - Beta (5Y monthly) 1.55
- PE ratio (TTM)
38.90 - EPS (TTM)
14.23 - Earnings date 2 Nov 2026
- Forward dividend & yield -- (0.00%)
- Ex-dividend date --
- 1y target est
698.00
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
www.idexx.com11,000
Full-time employees
31 December
Fiscal year ends
Healthcare
Sector
Diagnostics & Research
Industry
Recent news
View morePerformance overview
Trailing total returns as of 20/10/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD return
1-year return
3-year return
5-year return
Earnings trends
View moreAnalyst insights
View moreStatistics
View moreValuation measures
Market cap
41.08B
Enterprise value
41.98B
Trailing P/E
36.65
Forward P/E
31.45
PEG ratio (5-yr expected)
2.85
Price/sales (ttm)
9.18
Price/book (mrq)
25.48
Enterprise value/revenue
9.22
Enterprise value/EBITDA
25.98
Financial highlights
Profitability and income statement
Profit margin
25.03%
Return on assets (ttm)
27.09%
Return on equity (ttm)
74.21%
Revenue (ttm)
4.55B
Net income avi to common (ttm)
1.14B
Diluted EPS (ttm)
14.23
Balance sheet and cash flow
Total cash (mrq)
196.93M
Total debt/equity (mrq)
67.97%
Levered free cash flow (ttm)
909.37M
Compare
Select to analyse similar companies using key performance metrics; select up to four stocks.







